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FLIM techniqueHere we show the crucial role of MPP1 in lateral membrane ordering/organization in HEL cells (derived from
erythroid precursors). Biochemical analyses showed that inhibition of MPP1 palmitoylation or silencing of the
MPP1 gene led to a dramatic decrease in the DRM fraction. This was accompanied by a reduction of membrane
order as shown by ﬂuorescence-lifetime imaging microscopy (FLIM) analyses. Furthermore, MPP1 knockdown
signiﬁcantly affects the activation of MAP-kinase signaling via raft-dependent RTK (receptor tyrosine kinase)
receptors, indicating the importance of MPP1 for lateral membrane organization. In conclusion, palmitoylation
of MPP1 appears to be at least one of the mechanisms controlling lateral organization of the erythroid cell mem-
brane. Thus, this study, together with our recent results on erythrocytes, reported elsewhere (Łach et al., J. Biol.
Chem., 2012, 287, 18974–18984), points to a new role for MPP1 and presents a novel linkage between mem-
brane raft organization and protein palmitoylation.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
During the last few decades our understanding of the lateral hetero-
geneity of the cell membrane has been one of the most important
achievements in the biochemistry of biological membranes. Although
the molecular basis of lateral phase separation in model membranes
seems well understood, limited data are available on biological mecha-
nism(s) controlling Ld–>Lo phase separation and formation of rafts in
natural membranes. Currently, membrane rafts are deﬁned as dynamic
sterol-sphingolipid-enriched, ordered, unstable nanoscale assemblies
of proteins and lipids that might associate and disassociate spontane-
ously in the membrane [1–3]. It has been proposed that, in living cells,
these unstable, short-lived assemblies might be captured and stabilized
by lipid-anchored, transmembrane proteins or lipid domains to form
larger, more stable complexes deﬁned as resting-state rafts [2,4]. In re-
sponse to signaling, rafts are clustered into efﬁcient functionalized
signaling/sorting platforms that facilitate selective interaction betweenmistry, Biotechnology Faculty,
8 Wrocław, Poland. Tel.: +48
i).
l rights reserved.protein effectors including receptors, scaffolding molecules and signal
transducers [1,4,5]. The importance of membrane-rafts has been well
documented in numerous studies. However, despite the recent advances
in the understanding of membrane-raft function as a membrane-
organizing principle in many cellular processes, the question of how
cells regulate its formation remains open.
Proteins partition into rafts in response to speciﬁc signals. One
such signaling process is S-palmitoylation, a post-translational modi-
ﬁcation that occurs by attachment of palmitate to cysteine residues
of proteins via a thioester linkage. In contrast to other lipid modiﬁca-
tion, palmitoylation is the only one that can be dynamically regulated
enzymatically. This family of enzymes (protein–acyl transferases and
protein palmitoyl thioesterases) is currently being intensively ex-
plored [6–8]. As palmitoylation has a pleiotropic effect on proteins
and acts as a reversible switch that regulates their function and sub-
cellular distribution [6,9–11], much attention has been paid to its
crucial role in partitioning proteins into membrane-rafts [12–17].
However, data indicating that this modiﬁcation might be directly
involved in lateral membrane organization or domain formation are
limited. In our recent work [18] we found that palmitoylation of
the MAGUK-family protein, MPP1 (membrane palmitoylated protein
1/p55), which is known as an important component of the erythrocyte
membrane skeleton [19–23], regulates the lateral organization of the
erythrocyte membrane.
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tein in the membrane and from experiments on normal red blood
cells (RBC) in which PAT activity had been chemically inhibited, al-
lude to a link between protein palmitoylation, membrane organiza-
tion and the pathogenesis of hemolytic anemia.
As MPP1 is ubiquitously expressed in numerous cell lines and its
function is still poorly understood, in this studywe address the question
as to whether MPP1 and its palmitoylation is a key factor in the
switching mechanism that regulates lateral-membrane organization
in nucleated cells derived from erythroid precursors, using the HEL
(human erythroleukemia) cell line as a model to test this. Our experi-
ments involving the PAT inhibitor and a stable HEL cell line, inwhich ex-
pression of theMPP1 gene had been silenced by lentil viral vector-based
technology, show that the absence of (palmitoylated) MPP1 leads to
changes in lateral organization of the membrane, which could be ob-
served as 1) amarked decrease in theDRM fractions (detergent-resistant
membranes; deﬁned as low-density detergent-resistant membrane
fraction ﬂoating at 5/30% sucrose step gradient), 2) a reduction in mem-
brane order, indicated by the life-time values of di-4 probe, 3), changes in
CTxB distribution. Moreover, we provide direct evidence that observed
changes in membrane organization affect the function of membrane do-
mains, as MPP1 knockdown in HEL cells signiﬁcantly reduces activation
of MAP kinase signaling via raft-dependent RTK receptors. Thus, we pro-
pose that (palmitoylated) MPP1 controls resting-state membrane raft-
formation, facilitating selective and proper receptor activation and sub-
sequent downstream signal transduction in HEL cells.
2. Materials and methods
2.1. Isolation of DRM
For isolation of DRM from HEL cells, 15 × 106 cells were washed in
cold DRM-isolation buffer (10 mM Tris–HCl, 150 mM NaCl, 5 mM
EDTA, 100 μM PMSF, protease inhibitor cocktail, Sigma). Pellets were
suspended in 270 μl of the same buffer and 30 μl of 10% (w/v) Triton
X-100 was added, gently mixed, and incubated for 20 min on ice with
occasional vortexing. The samples were then mixed with an equal vol-
ume of 80% sucrose in the DRM-isolation buffer, overlaid with 2.7 ml
of 30% sucrose and 0.9 ml of 5% sucrose and ultracentrifuged in a
Beckman 60Ti SW rotor (16 h, 35,000 rpm, 4 °C).
2.2. Biochemical analysis of DRM fraction
After DRM isolation, 10 fractions (420 μl) were collected from the
top of the gradient. In each fraction, protein (BCA, Bio-Rad) and choles-
terol (AmplexRed Cholesterol Assay Kit, Invitrogen) concentrations
were measured as described in the manufacturer's protocols. Measure-
ments were performed using a Cary 1E UV–Visible Spectrophotometer
and a Cary Eclipse Spectroﬂuorimeter.
2.3. Protein separation, immunodetection, and detection of radiolabeled
polypeptides
Proteins were electrophoresed by SDS-PAGE (10% gel) [24], stained
in 0.01% Coomassie Blue in 5% acetic acid/10% ethanol or transferred
onto a nitrocellulose membrane (PROTRAN®, Schleicher & Schuell
Bioscience) in transfer buffer (192 mM glycine, 0.01% SDS, 20% metha-
nol, pH 9.2) [25]. The proteins in each collected fraction from the sucrose
gradient were precipitated with 10% TCA prior to electrophoresis. TCA
precipitates were electrophoresed as above.
Primary antibodies used for protein detection were: monoclonal
mouse anti-MPP1, polyclonal rabbit anti-ﬂotillin 1, polyclonal goat
anti-ﬂotillin 2, polyclonal rabbit anti-actin (all fromAbcam), polyclon-
al goat anti-stomatin (Santa Cruz), mouse anti-ERK1/2, rabbit
anti-phospho-ERK1/2 (Cell Signaling). Secondary antibodies (anti-goat,
anti-rabbit, or anti-mouse; 0.04 μg/ml) conjugated with horseradishperoxidase were used (Jackson ImmunoResearch). Reactions were de-
veloped by ECL procedure using luminol and coumaric acid (both from
Sigma) as substrates and exposed on a UVP Multispectral Imaging
System.
The detection of radiolabeled peptides was done by exposure of
the nitrocellulose or dried gels to a Molecular Dynamics storage phos-
phor screen, which was scanned in a Typhoon 8600 scanner.
2.4. 2-Bromopalmitate treatment and labeling of palmitoylated proteins
Radioactive labeling of palmitoylated proteins in HEL cells (15 × 106)
with (14C)-palmitic acid (Hartmann Analytic) after 2-BrP treatment was
performed as described [26]. For inhibition of palmitoylation, 15 × 106
HEL cells were incubated with 100 μM 2-BrP in complete RPMI medium
for 20 h in a humidiﬁed cell culture chamber (37 °C, 5% CO2). After incu-
bation, cells were washed three times with PBS buffer, centrifuged for
5 min, 1000 ×g, 4 °C and separated in SDS-PAGE electrophoresis.
2.5. MPP1 gene expression silencing in HEL cells
MPP1 gene silencing was done using ‘p55 shRNA Lentiviral Particles’
(Santa Cruz). For transduction, cells were plated in a 12-well plate to
50% conﬂuence in RPMI medium (supplemented with 10% fetal calf
serum [FCS], PSG mix) and infected with 20 μl of p55 shRNA lentiviral
particles or 20 μl of control shRNA lentiviral particles (scrambled)
according to the manufacturer's protocol. Stable clones expressing
shRNA were selected using 2 μg/ml puromycin dihydrochloride (Santa
Cruz). Total RNA was isolated from cells (RNeasy Isolation Kit, Qiagen)
and cDNA was obtained using DyNAmo cDNA Synthesis Kit for
qRT-PCR (Finnzymes). Expression of MPP1 was analyzed by: 1) PCR re-
action using the following primers for MPP1: forward: 5′-ATC TCG AGT
CAC CAT GAC CCT CAA GGC GA-3′; reverse: 5′-GCA AGC TTA TTA GTA
AAC CCA GGA GAC AGG-3′; and 2) by Western blot from cell lysates
by using anti-MPP1 mouse antibodies. The loading cDNA control for
the PCR reaction was based on beta-actin primers (forward: 5′-TAC
AAT GAG CTG CGT GTG GCT CCC G-3′; reverse: 5′-AAT GGT GAT
GACCTG GCC GTC AGG C-3′). Actin was used as a protein-loading con-
trol and detected on Western blot using anti-actin antibodies. It is
worth to notice that both scrambled andMPP1 knockdown cells select-
ed on puromycin varied in size and were rather smaller than the
untreated control HEL cells. In order to test for off-target effect, two pro-
cedures were carried out: i. computer analysis of sequences used for
off-target effect and ii. Transient silencing of MPP1 gene expression by
electroporation (Lonza CLB-Transfection™ System) of HEL cells using
two independent siRNA oligonucleotide systems (Santa Cruz and
OriGene) (Supplementary Fig. 5).
2.6. MßCD treatment of HEL cells
For DRM isolation after cholesterol depletion, 15 × 106HEL cellswere
incubated with 10 mMMßCD (Sigma) as previously described [27]. Via-
bility of the cells was checked by Trypan Blue (Sigma) staining and was
not affected after this treatment (not shown). For immunoﬂuorescence
staining, cells were incubated with 10 mM MßCD in a 12-well plate for
30 min in a humidiﬁed cell culture chamber (37 °C, 5% CO2), centrifuged
(5 min, 1000 ×g), washed with PBS and ﬁxed with paraformaldehyde
(ﬁnal PFA concentration 2%, 10 min, RT). After washing three times
with PBS, cells were centrifuged directly onto poly-L-lysine coated
glass coverslips and used for immunoﬂuorescence staining.
2.7. Immunoﬂuorescence staining
For immunostaining analysis, HEL cellswerewashed three timeswith
PBS, centrifuged (5 min, 1000 ×g, RT) and ﬁxed as described above. Cells
were centrifuged directly onto poly-L-lysine coated glass coverslips
(5 min, 1000 ×g, RT) and dried for 15 min, RT. After permeabilization
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times in PBS, blocked with FCS (20 min, RT), and incubated for 1 h with
primary antibodies (anti-MPP1 or anti-ﬂotillin1), washed as above and
further incubated with secondary antibodies (donkey anti-mouse-Cy 2
or goat anti-rabbit-Cy 5) in the dark. Cells were washed as above and
incubated for 15 min with mounting medium containing DAPI.
2.8. CTxB incubation with HEL cells
HEL cells (1 × 106) were washed with ice cold PBS and incubated
with 10 μg of CTxB-Alexa Fluor 647 (Invitrogen) for 15 min on ice.
After incubation, cells were washed immediately and ﬁxed with ice-
cold PFA (on ice) as described above. After washing, cells were cen-
trifuged onto glass coverslips and incubated with mounting medium
containing DAPI as described previously.
2.9. Activation of MAP kinase downstream signaling in HEL cells
Control and MPP1 knockdown HEL cells were grown in 12-well
plates (2 ∗ 105 cells/well) and serum-starved for 16 h before treatment
with human recombinant SCF (R&D Systems) (10 ng/ml) or insulin
(1 μg/ml) for 15 min in a humidiﬁed cell culture chamber (37 °C, 5%
CO2). After stimulation, cells were harvested, washed twice with ice-
cold PBS and lysed for 30 min on ice in lysis buffer (50 mM HEPES,
pH 7.5, 100 mM NaCl, 1 mM EDTA, 10% glycerol, 0.5% NP-40) sup-
plemented with protease inhibitor cocktail (Sigma) and phosphatase
inhibitors (Santa Cruz), and separated via SDS-PAGE (12% gel), followed
by Western blot analysis.
2.10. Microscopy and data analysis
Images were acquired on a LSM 510 META microscope (Carl Zeiss,
GmbHGermany) using a PLAN-APOCHROMAT 63x/1.4 OIL DICM27 ob-
jective. Image acquisition was performed using ZEN 2009 Light Edition
software. Representative cells were chosen to indicate signiﬁcant differ-
ences between controls and 2-BrP/MβCD/MPP1 knockdown treated
cells. However, images containing larger numbers of cells, as well as
image plot analysis are presented in Supplementary Figs. 3 and 4.
2.11. Fluorescence lifetime measurement by time correlated single
photon counting (TCSPC) FLIM
FLIM was used to measure the ﬂuorescence lifetime of the
membrane-order sensitive probe, di-4 (Invitrogen). HEL cells (control,
2-BrP treated, scrambled, MPP1 knock down, MßCD treated, all sus-
pended in RPMI complete medium) were transferred onto 40 mm di-
ameter poly-L-lysine coated round cover-slips and left for 20 min in a
humidiﬁed cell culture chamber at 37 °C, 5% CO2. Cells were washed
twice and stained with 7.5 μM di-4 in RPMI medium for 30 min. Cells
were washed twice and coverslips were then mounted in a heated mi-
croscope stage and left for 10 min at 37 °C for further FLIM analysis.
Time domain FLIM was performed with an LSM 510 META microscope
(Carl Zeiss, GmbH, Germany) upgraded with FLIM and FCS capabilities
with a dedicated kit (PicoQuant, GmbH, Germany). The probe was ex-
cited with a 470 nm pulsed laser diode with a 40 MHz repetition rate
and observed with a 40× C-Apochromat water immersion objective
(NA 1,2) and ﬂuorescence was collected through a 500 nm long wave
pass ﬁlter. Laser power was adjusted to give an average photon rate of
104–105 photons in order to avoid the pile-up effect. Acquisition time
depended on the brightness of the sample and was in the range of
200 s, in order to achieve a sufﬁcient number of photons per pixel
(at least 103). Each pixel in the image was pseudo-colored according
to the average ﬂuorescent lifetime. The size of the images was
256 × 256 pixels. Improvement of the ﬂuorescent lifetime estimation
was achieved by 2 × 2 pixel binning. Lifetime analysis of di-4 in HEL
cell images was performed after an appropriate region of interest(ROI), containing only the plasmamembrane, was selected as previously
described [28,29].
3. Results
3.1. Inhibition of palmitoylation correlates with a reduction of DRM
fraction in HEL cells
As mentioned above in the Introduction, it was found that a linkage
exists between palmitoylation of theMPP1 protein, DRM formation and
hemolytic anemia. As HEL cells are derivatives of hematopoietic precur-
sors, it was interesting whether the effect of palmitoylation inhibition
on DRM formation in these cells would be similar.
Autoradiography of SDS electropherograms of HEL cells incu-
bated with 14C-palmitate in the presence or absence of 2-BrP (2-
bromopalmitate), a commonly used palmitoylation inhibitor, indicat-
ed that the presence of 100 μM 2-BrP completely suppressed the
palmitoylation reaction of numerous proteins detected in control
HEL cell lysates (Fig. 1A upper panel), but did not affect MPP1 level
(Fig. 1 A lower panel). As DRM correlates with membrane rafts, we
checked the effect of inhibition of protein palmitoylation (100 μM
2-BrP) on the amount of detergent-resistant membrane fraction.
Comparison of the results of membrane fractionation with cold Triton
X-100 solution before and after incubation with 2-BrP shows a con-
siderable decrease in the DRM fraction. The cloudy zone of the DRM
was nearly absent at the 5/30% interface of the sucrose gradient
(Fig. 1B). The net protein content was two-fold lower, and cholesterol
as much as four-fold lower, in 2-BrP-treated HEL cell-derived DRM
(fractions 2–4), compared to the control (Fig. 1C). When the protein
proﬁle of DRM of the control and 2-BrP treated cells were analyzed,
MPP1 and other membrane raft markers, which are also known to
be palmitoylated (ﬂotillin-1 and -2 and stomatin), were enriched in
the DRM fractions from the control cells but, interestingly, only MPP1
was absent from theDRM fraction after 2-BrP treatment (Fig. 1D). In ad-
dition, when the experiment with methyl-β-cyclodextrin (MβCD) was
used to disrupt normal lateral-membrane organization, the observed
changes in the gradient centrifugation proﬁle of Triton X-100 solubi-
lized membranes resembled those obtained after 2-BrP treatment
(Fig. 1B–D). It should be noted that proper DRM localization in the den-
sity gradient was observed when the experiments were carried out in
the presence of DMSO and/or 100 μM palmitic acid (Supplementary
Fig. 1). Based on these observations, the obtained data could be
interpreted as if that the lack of MPP1 protein palmitoylation coincides
with a marked decrease in the DRM of HEL cell membranes.
3.2. MPP1 knockdown is linked to a marked decrease in DRM fraction in
HEL cells
As in HEL cells not only MPP1 is a PAT substrate (Fig. 1A), to deter-
mine whether the presence of MPP1 itself is crucial for the proper lat-
eral membrane organization in HEL cells, the effect of silencing of
MPP1 gene expression was studied by using stable cell lines obtained
by lentiviral shRNA technology (see Materials and methods). As can
be seen in Fig. 2A–B, its expression was markedly reduced (>60%)
at both the mRNA (left) and protein (right) levels. Interestingly,
when DRMs were isolated from such cells, a marked decrease in the
obtained low-density fractions (fractions 2–4) was observed as com-
pared to “wild-type” or “scrambled” control (Fig. 2C–D). Biochemical
analysis of collected fractions revealed similar reduction in the
amount of protein (two-fold lower) and cholesterol (three-fold
lower) in residual DRM from MPP1 knockdown membranes, as in
the case of either 2-BrP or MßCD treated cells (Figs. 1C and 2D). It
should be noted that the total protein and cholesterol level in controls
and MPP1 knockdown cells was comparable to each other. When we
checked the distribution of ﬂotillins and stomatin in sucrose gradient
fractions in MPP1 knockdown cells (Fig. 2E) we observed the same
Fig. 1. Inhibition of palmitoylation with 2-bromopalmitate affects the DRM proﬁle of cultured HEL cells. (A) 20 h treatment with 100 μM 2-BrP signiﬁcantly decreases the
palmitoylation of proteins in HEL cells. Control and 2-BrP treated HEL cells incubated with 14C-palmitate were subjected to 10% SDS-PAGE. Detection of 14C-palmitate radiolabeled
peptides was done by scanning dried, Coomassie-blue stained gel using a Typhoon 8600 scanner. Western blot analysis showed that 2-BrP does not affect MPP1 expression level in
HEL cells. (B) Isolation of DRM from 100 μM 2-BrP/MβCD treated HEL cells results in the reduction of a lipid–protein cloudy zone (site of DRM) from the low-density zone compared
to control. (C) 2-BrP treatment changes the low-density fraction content (protein concentration, upper panel; cholesterol concentration, bottom panel) in a similar way to MßCD
treatment compared to control HEL cells (mean ± S.D.; n = 5); inset shows enlarged scale for total protein and cholesterol content in DRM (fractions 2–4); statistical analysis was
performed using Student's t-test. Differences were considered statistically signiﬁcant at p b 0.05 (*), p b 0.01 (**), p b 0.001 (***). (D) Western blot showing distribution proﬁle
before or after 2-BrP/MβCD treatment of HEL of MPP1, stomatin, ﬂotillin-1, and ﬂotillin-2 after sucrose gradient fractionation of Triton X-100-treated cells (DRM isolation).
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(Fig. 1D) which, in general, suggests that the absence of MPP1 itself
seems to be a key factor directly linked to the loss of DRM in HEL cells.
3.3. An absence of (palmitoylated) MPP1 changes the order-sensing dye
di-4 lifetime values
An order-sensing probe, di-4,was used in aﬂuorescence lifetime im-
aging microscopy (FLIM) study to detect changes in the lateral mem-
brane domain order following chemical inhibition of palmitoylation
and MPP1 silencing in HEL cells. The probe exhibits a lifetime shift
between liquid disordered (Ld) and liquid ordered (Lo) phases and,
recently, has been used to study the distribution of membrane lipid
order in living cells [28,29]. As shown in Fig. 3, either inhibition of
protein palmitoylation or marked reduction of MPP1 protein in HEL
cells alters the physicochemical state of the membrane bilayer, as was
detected by decreased lifetime values of the dye compared to the con-
trols (Fig. 3A–C). Interestingly, in both cases, the shift in lifetime value
was close to 0.3 ns. As was checked in the experiment, the changes in
membrane ordering cannot be an effect of the solvent, as both the
DMSO and palmitic acid treatment showed no signiﬁcant variations in
lifetime values of the dye (Supplementary Fig. 2). Thus, the observed re-
duction in membrane-order was directly correlated with the presenceof (palmitoylated) MPP1. Furthermore, the direction of the changes
was similar to those obtained after treatment of cells with 10 mM
MβCD (Fig. 3A–C), although the effect of 2-BrP or MPP1 knockdown
was less dramatic. Taken together, these results provide evidence that
the reduction in (palmitoylated) MPP1 content accompanied by ob-
served loss in DRM has direct consequences for the physicochemical
properties of HEL cell membranes.
3.4. Membrane distribution of CTxB, MPP1 and ﬂotillin 1 changes upon
inhibition of palmitoylation and/or MPP1 silencing
BecauseMPP1was shown to affect membrane organization, we sub-
sequently investigated the changes in thedistribution of this protein and
other markers associated with detergent-resistant membrane within
the cell after inhibition of palmitoylation, MPP1 knockdown or MβCD
treatment. Our immunoﬂuorescence analysis showed that, after 2-BrP
treatment MPP1, ﬂotillin 1 as well as CTxB (cholera toxin B) were dis-
tributed mainly in cytoplasm compared to the control (Fig. 4A–C),
where they remained in the plasmalemma. Moreover, the same results
were obtained when the expression of MPP1 was silenced in HEL cells
(Fig. 4A–C bottom), or whenmembrane rafts were disrupted by choles-
terol depletion using MβCD (Fig. 4D–F). The observed similarity be-
tween the rearrangement of CTxB and ﬂotillin 1 in MPP1 knockdown
Fig. 2. Presence of (palmitoylated) MPP1 is indispensable for normal membrane lateral organization as reﬂected by the amount of DRM fraction. (A) MPP1 gene expression silencing
(KnD) in HEL cells using shRNA lentiviral particles: PCR products (left) and Western blot analysis (right). Actin was used as a loading control. (B) Densitometric analysis indicated that
the expression of MPP1 was markedly diminished in mRNA (left) and protein (right) level compared to controls. (C) Silencing of MPP1 expression is correlated with a reduction in
the cloudy zone at 5/30% sucrose gradient. (D) Protein and cholesterol proﬁles of MPP1 KnD cells resemble the DRM proﬁle of 2-BrP treated HEL cells (mean ± S.D.: n = 5); inset
shows enlarged scale for total protein and cholesterol content in DRM (fractions 2–4); see also Fig. 1 legend. (E) Western blot proﬁle of DRM fraction from scrambled (upper) and
MPP1 KnD HEL cells.
1880 A. Biernatowska et al. / Biochimica et Biophysica Acta 1833 (2013) 1876–1884cells and that obtained after raft disruption viaMβCD treatment strongly
supports the role of MPP1 in membrane organization postulated here.
3.5. MPP1 silencing affects the activation of MAP kinase signaling
Membrane rafts are known to play a crucial role in assembling
membrane receptors, initiating their activation and facilitating further
signal transduction [1,5]. It has been well documented that both
receptors and many of their adaptor molecules localize speciﬁcally
to rafts. One well-studied example is raft-dependent activation of
MAP kinase signaling that occurs via many receptor tyrosine kinases,including insulin receptor and c-kit receptor [1,30,31]. To test whether
observed MPP1-driven changes in lateral membrane organization
might correlate with loss of resting-state raft formation, we analyzed
the activation of MAP kinases ERK1/2 upon stimulation of MPP1
knockdown HEL cells with SCF or insulin. Indeed, we observed sig-
niﬁcantly reduced activation of MAP kinase activity, measured as
phospho-ERK1/2 level inMPP1 knockdown cells stimulated with either
factors, compared to controls (Fig. 5A–D). Fold increases of p-ERK 1/2
in both cases were approximately two-times lower after stimulation
than in scrambled and control HEL cells. Although these two receptors
act independently, both require the presence of rafts to activate the
Fig. 3. The distribution of ﬂuorescence lifetime values of di-4 changes upon inhibition of palmitoylation or silencing of MPP1 expression. (A–C) The ﬂuorescence lifetime histograms
(B) and FLIM images (A) for di-4 probe of control, 2-BrP treated, scrambled,MPP1KnD andMβCD treated cells. 2-BrP treatment andMPP1 gene silencing results in reduced lifetime values
of the probe compared to the controls. (C) Quantitative analysis shows signiﬁcant reduction of average lifetime values for control (3.5 ns), scrambled (3.52 ns),MPP1 KnD (3.22 ns) and
2-BrP (3.21 ns) or MβCD (2.7 ns) treated HEL cells (for each n = 15) (p b 0.0001). Statistical analysis was performed using Student's t-test. All scale bars represent 10 μm.
1881A. Biernatowska et al. / Biochimica et Biophysica Acta 1833 (2013) 1876–1884downstream signaling pathways [31–35]. Thus, the obtained results in-
dicate that marked reduction in MPP1 in HEL cells results in signiﬁcant
inhibition of MAP kinase signaling, pointing to the role of this protein in
proper lateral membrane organization crucial for signal transduction.Fig. 4. Lack of (palmitoylated) MPP1 changes CTxB, MPP1, and ﬂotillin 1 distribution in HEL
induces CTxB cytoplasmic internalization in 2-BrP treated or MPP1 KnD HEL cells. (B and C
markedly different. (D–F) Depletion of cholesterol by MßCD in HEL cells resembles the effe
quired on an LSM 510 META microscope (Carl Zeiss, GmbH Germany) using a PLAN-APOCH
2009 Light Edition software. Single confocal planes in all shown experiments were taken fr4. Discussion
Although there are numerous studies indicating the importance
of protein palmitoylation for proper membrane-targeting into ‘rafts’cells and resembles the cholesterol depletion effect. (A) Lack of (palmitoylated) MPP1
) Localization of MPP1 and ﬂotillin 1 in controls, 2-BrP treated and MPP1 KnD cells is
ct of 2-BrP treatment. HEL cells were incubated with 10 mM MßCD. Images were ac-
ROMAT 63x/1.4 OIL DIC M27 objective. Images acquisition was performed using ZEN
om the central z-stack position. Bars represent 10 μm.
Fig. 5. MPP1 knockdown affects activation of MAP kinase downstream signaling. (A, C) WB analysis of MAP kinase activation measured by the level of phospho-ERK1/2 in controls
and MPP1 knockdown cells stimulated by either SCF (A) or insulin (C); total ERK was used as a loading control. (B, D) Densitometric quantiﬁcation of the p-ERK 1/2 is shown. The
values were normalized assuming that fold increase in normal cells after stimulation is 100% (1.5–2.5-fold) of the p-ERK level at time 0. Data shown represent two separate exper-
iments; Error bar, ±S.D.
1882 A. Biernatowska et al. / Biochimica et Biophysica Acta 1833 (2013) 1876–1884[9,13,14,16,17,36–39], the data showing that this process might be
indispensable for resting-state raft formation are limited. Recently pub-
lished results on erythrocytemembranes derived frompatientswith he-
molytic anemia, inwhichpalmitoylatedMPP1 could not be detected due
to an unknowndefect resulting in the lack of DHHC17 protein in the RBC
membrane, or on normal RBC in which palmitoylation was inhibited,
indicate a crucial role for this protein in lateral organization of themem-
brane [18]. As the role ofMPP1 in erythroid cells is still poorly character-
ized, it was important to determine whether the same or a similar
mechanism is active in nucleated cells in which not only palmitoylation
inhibition, but, also MPP1 gene-silencing experiments were possible.
Further, nucleated cells offer the possibility to test the function of
known raft-dependent signaling pathways which essentially are absent
from erythrocytes. Thus, the objective of this study was to explore
whether MPP1 and its palmitoylation may act as a physiological switch
that regulates lateral membrane organization in HEL cell membranes.
Our experiments clearly showed that palmitoylation inhibition and/or
MPP1 silencing is responsible for the lateral organization of the HEL cell
membrane, as was detected by a marked decrease of the DRM fraction,
changes in cellular distribution of raft markers, and changes in mem-
brane order detected by FLIM experiments of the di-4 probe. Moreover,
it was found that silencing of MPP1 gene expression affects the activa-
tion of theMAP kinase signalingpathway via raft-dependent RTK recep-
tors, pointing to its potential role in membrane domain formation.
The direct correlation between palmitoylation and membrane-raft
formation in HEL cells seems to be evident, as only MPP1, but not other
proteins, well-known raft markers that are known to be palmitoylated,
e.g. stomatin or ﬂotillins (reggies), were missing from the DRM fraction,
the amount of which was markedly reduced when palmitoylation was
inhibited (Fig. 1). Notably, the same effect was observed when the ex-
pression of MPP1 was stably silenced by shRNA (Fig. 2), suggesting the
speciﬁc role of MPP1 in this process. In addition, marked reduction of
the DRM fraction was observed when the expression ofMPP1was tran-
siently silenced using two independent siRNA systems (Supplementary
Fig. 5), indicating that the observed changes did not originate from theoff-target effect in HEL cells and/but are strictly related to the decrease
of MPP1. Also, bioinformatics analysis [40,41] did not indicate signiﬁcant
probability of the off-target effect (data not shown).
Although there is no simple relationship between DRM and mem-
brane rafts, DRM isolation and characterization is still considered a
useful tool, providing some insight into their lateral organization
[27,42]. Signiﬁcantly, the observed decrease in the amount of DRM
was accompanied by a decrease in membrane-order in HEL cells: the
characteristic shift towards lower lifetime values of di-4 probe was
observed only when MPP1 was not palmitoylated and/or its cellular
level was reduced (Fig. 3). It is also worth noting that the pattern of
morphological changes and distribution of CTxB, MPP1, and ﬂotillin 1
following 2-BrP treatment or MPP1 silencing were similar (Fig. 4A–C).
However such re-localization of raft markers especially CTxB and
ﬂotillin 1 is intriguing, and not simple to explain. In our opinion, its
presence in the cytoplasm (cytoplasmic vesicles) observed upon dis-
rupting of lateral membrane organization, might resemble the process
of ﬂotillin-dependent endocytosis observed previously by Glebov et al.
[43]. Nevertheless, detailed characterization of this process should be
investigated in future studies. Moreover, as far as the presence of
ﬂotillin and other raft markers in the DRM fractions is concerned
(Figs. 1D, 2E) after membrane disorganization, we suggest that this is
due to the fact that unpalmitoylated MPP1 dissociating from “resting-
state rafts” induces their disassembly but does not affect their detergent
solubility. Additionally, similar raft marker distribution in the sucrose
gradient proﬁle was observed by us when RBC were treated with
2-BrP in a time-dependent manner (unpublished data), indicating that,
if the palmitoylation process was not efﬁcient enough (3–6 h), these
raft markers were still associated with DRM fractions.
In addition, for all experiments a kind of ‘positive control’ by using
a commonly used membrane raft disrupting agent, MßCD, was
performed. In all cases, changes observed in MPP1 distribution in
density-gradient fractions (Fig. 1), as well as its distribution within the
cells (Fig. 4) afterMßCD treatment, seemed to be analogous. Amore dra-
matic difference was detected in FLIM analysis, as the lifetime value of
1883A. Biernatowska et al. / Biochimica et Biophysica Acta 1833 (2013) 1876–1884di-4 was considerably reduced (1.2 ns) (Fig. 3). This might be due to the
global effect of cholesterol depletion from cells by MßCD treatment,
although the direction of the changes showed a similar tendency.
An important question is how MPP1 affects the organization of the
membrane domains. Our hypothesis is that, upon palmitoylation, the
afﬁnity of MPP1 for membrane-skeleton binding decreases and MPP1
becomes available for binding the pre-existing nanoclusters or ‘unstable
rafts elements’, i.e., protein-cholesterol/lipid complexes corresponding
to cholesterol-depletion sensitive, short-lived (b0.1 ms) nanoclusters
(b10 nm in diameter) observed previously by others [44–46]. This
suggestion is based on the observations that, in RBC and in HEL cells,
the unpalmitoylated MPP1 remains in the high-density “skeletal” frac-
tion in the density-gradient proﬁle of the DRM (Fig. 1D). Binding of
(palmitoylated) MPP1 to the pre-existing domains induces their fusion
into nanodomains and stabilizes them as membrane “rafts” (resting-
state rafts) which are larger (~20 nm) in diameter [47], more stable
and detergent-resistant domains which become functional. This is
consistent with the model of Hancock [2]. Since palmitoylation has
been reported previously to be involved in regulation of membrane-
protein clustering, such as tetraspanin [48,49] or GABAA receptors
[50], and has also been shown to promote oligomerization of certain
proteins [11,51], we speculate that palmitoylated MPP1 in erythroid
cells plays a role in raft protein(s) oligomerization. Our prelimi-
nary co-immunoprecipitation experiments indicate that MPP1 bound
ﬂotillin 1 and ﬂotillin 2 (Biernatowska et al. unpublished). As it is
known that ﬂotillins are involved in nanocluster formation (above-
mentioned raft protein oligomerization), we hypothesize that binding
of palmitoylated MPP1 underlies the molecular mechanism of resting-
state raft formation. This rearrangement is connected to a change in
membrane-lipid properties resembling formation of the Lo phase and
its separation from the bulk Ld phase membrane. Lack of palmitoylated
MPP1, due to its absence or inhibition of palmitoylation, reduces this or-
dering, which was detected as smaller values in the ﬂuorescence life-
time of di-4 and a marked decrease in the DRM fraction. Palmitoyl
chains could participate in “raft” formation as proposed previously
[52] by means of “lipid shells” that form around lipid anchors, function-
ing as targeting elements to allow interaction of the shelled pro-
teins with pre-existing membrane rafts or caveolae. Whether or not
this mechanism (resting state raft formation) is involved in protein
palmitoylation-dependent processes in other nucleated cells should
be the subject of further studies. It should be noted that similar function
was recently suggested for palmitoylation of Rac1 in COS-7 and MEF
cells [53], but these authors implicate the actin skeleton in the mecha-
nism of raft clustering. In our opinion, the mechanism could involve
the release of MPP1 from the actin skeleton. Data published by others
[54] onMPP1 knockout mutant mice indicated that MPP1 was required
for neutrophil polarization, by regulating Akt phosphorylation in the
PI3K gamma independent pathway, but no molecular mechanism(s)
was suggested. Our data may explain the role of MPP1 in the described
process. Furthermore, the results presented here indicate that silencing
of theMPP1 gene affects the signaling ofMAP kinase that is activated via
many receptor tyrosine kinases including the insulin receptor or c-kit
receptor, a process which is well known to be “raft” dependent
(Fig. 5). Thus, the obtained results indicate that a marked reduction in
MPP1 in HEL cells results not only in changes of physicochemical prop-
erties of the membrane, but also in signiﬁcant inhibition of MAP kinase
signaling. The fact of raft-dependence of many signaling pathways is
well known in cell biology, but availability of data concerning “endoge-
nous” factors regulating raft formation is rather limited. Therefore, our
results show a new role for MPP1 in lateral organization of the mem-
brane of cells of erythroid origin.
5. Conclusions
In conclusion, this study presents the physiological mechanism in
which MPP1 and its palmitoylation appears to play a crucial role inhow cells regulate domain/raft formation. Moreover, marked reduction
in MPP1 in HEL cells results not only in changes of physicochemical
properties of the membrane (similar to the effect of inhibition of
palmitoylation), but also in signiﬁcant inhibition ofMAPkinase signaling.
We speculate that the binding of palmitoylatedMPP1 to the pre-existing
nanoassemblies induces their fusion into nanodomains and stabilizes
them as larger (~20 nm diameter) “resting state rafts” that are more
stable and detergent-resistant domains which become functional.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbamcr.2013.03.009.
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